KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Jun 02, 2021 $0.0643 $0.0800 $0.0643 $0.0740 59 873
Jun 01, 2021 $0.0790 $0.0790 $0.0714 $0.0740 59 873
May 28, 2021 $0.0625 $0.0790 $0.0625 $0.0790 20 580
May 27, 2021 $0.0800 $0.0800 $0.0581 $0.0790 12 392
May 26, 2021 $0.0750 $0.0795 $0.0699 $0.0700 29 200
May 25, 2021 $0.0835 $0.0835 $0.0578 $0.0795 10 344
May 24, 2021 $0.0830 $0.0830 $0.0575 $0.0699 6 488
May 21, 2021 $0.0785 $0.0785 $0.0575 $0.0785 22 497
May 20, 2021 $0.0576 $0.0875 $0.0564 $0.0785 22 497
May 19, 2021 $0.0785 $0.0785 $0.0576 $0.0699 3 530
May 18, 2021 $0.0580 $0.0785 $0.0580 $0.0784 12 425
May 17, 2021 $0.0800 $0.0800 $0.0564 $0.0785 65 273
May 14, 2021 $0.0870 $0.0870 $0.0777 $0.0800 13 473
May 13, 2021 $0.0742 $0.0890 $0.0645 $0.0890 46 869
May 12, 2021 $0.0755 $0.0755 $0.0640 $0.0744 41 612
May 11, 2021 $0.0648 $0.0755 $0.0648 $0.0652 718
May 10, 2021 $0.0670 $0.0754 $0.0640 $0.0667 7 767
May 07, 2021 $0.0708 $0.0777 $0.0641 $0.0696 37 944
May 06, 2021 $0.0757 $0.0757 $0.0640 $0.0756 34 406
May 05, 2021 $0.0640 $0.0757 $0.0640 $0.0757 28 134
May 04, 2021 $0.0652 $0.0757 $0.0650 $0.0756 7 653
May 03, 2021 $0.0775 $0.0775 $0.0640 $0.0757 21 938
Apr 30, 2021 $0.0777 $0.0777 $0.0650 $0.0775 46 361
Apr 29, 2021 $0.0898 $0.0900 $0.0655 $0.0880 14 669
Apr 28, 2021 $0.0900 $0.0900 $0.0653 $0.0790 11 603
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT